Market Tracker

06/28 5:16pm ET

Sanofi SA (NYSE:SNY)

49.29
Delayed Data
As of 4:02pm ET
 0.00 / 0.00%
Today’s Change
36.81
Today|||52-Week Range
50.24
+21.88%
Year-to-Date
Seattle Genetics (SGEN) Reports Positive Data for Adcetris
Jun 27 / Zacks.com - Paid Partner Content
Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout
Jun 23 / TheStreet.com - Paid Partner Content
Sanofi/Regeneron's Kevzara Gets Marketing Approval in EU
Jun 27 / Zacks.com - Paid Partner Content
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
Jun 22 / Zacks.com - Paid Partner Content
Amgen Gets Positive CHMP Opinion for Mimpara Label Expansion
Jun 27 / Zacks.com - Paid Partner Content
Why You Should Add Novo Nordisk Stock to Your Portfolio
Jun 22 / Zacks.com - Paid Partner Content
Good Companies From Warren Buffett's Portfolio
Jun 23 / GuruFocus News - Paid Partner Content
Seattle Genetics (SGEN) Submits BLA to FDA for Cancer Drug
Jun 21 / Zacks.com - Paid Partner Content
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Jun 23 / Zacks.com - Paid Partner Content
Horizon Pharma Gets Health Canada Approval for Procysbi
Jun 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close49.29
Today’s open49.36
Day’s range49.19 - 49.48
Volume830,258
Average volume (3 months)1,765,004
Market cap$126.9B
Dividend yield3.33%
Data as of 4:02pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)+11.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.35%
Revenue growth (last year)-2.08%
P/E ratio29.1
Price/Sales2.81
Price/Book2.04

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.53+0.73%
GSKGlaxoSmithKline-0.21-0.48%
CELGCelgene+3.38+2.58%
BMYBristol-Myers Squibb-0.03-0.05%
Data as of 4:14pm ET, 06/28/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)$0.73
Annual revenue (last year)$37.3B
Annual profit (last year)$5.2B
Net profit margin12.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts